Sigmund Silber, MD, PhD Professor of Medicine
FESC, FACC, FAHA
Cardiologist

70

PLEASE NOTE:
For more Congress Presentations, please see also the VIDEO Section:
http://www.sigmund-silber.com/cms/english/videos

 


69

ESC Congress (European Society of Cardiology)
Munich, 29th of August 2018
Best Poster: M. Keller, M. Rippel, S. Silber:
Side effects of regadenoson replacing adenosine for pharmacological stress tests in real world: prospective evaluation in over 5000 patients
Abstract


68

ESC Congress (European Society of Cardiology)
Munich, 25th of August 2018
Oral Presentation Prof. Silber
Congress Condensed: Coronary Heart Disease
Program


67

American College of Cardiology (ACC)
Orlando, 11th of March 2018
IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS
JACC March 20, 2018 Volume 71, Issue 11
Abstract
Poster


66

18. Annual Congress of NFIC (New Frontiers in Interventional Cardiology)
Krakow, 7th and 8th of December, 2017
Chairman and Oral Presentation Prof. Silber:
Usefulness of pharmacological stress tests with Regadenosone: Experience in over 4000 patients in a cardiology practice in Germany
Program
Letter of Appreciation


65

Annual Congress of the CIAT
(Cardiovascular Intervention Association of Thailand)

Bangkok, 18th of November 2017
Oral Presentation Prof. Silber:
Should all DAPTs post PCI be new P2Y12 ?
Program


64

TCT Congress, Denver, Colorado
29th of October - 2nd of November 2017
Chairman and Oral Presentation Prof. Silber:
Promus Element Everolimus-Eluting Stents: Device Iterations
and Randomized/Registry Outcomes Data in Perspective

Program


63

Annual Congress of the European Society of Cardiology (ESC)
Barcelona, 30th of August 2017
Oral Presentation Prof. Silber:
Congress Condensed - General Cardiology
Coronary Artery Disease

Program


62

Great Minds - Expert Meeting
Budapest, June 23rd 2017
Presentation Prof. Silber:
Old and New Effective Strategies for LDL-Cholesterol Reduction
(Video Duration: 18:46)


61

EuroPCR Kongress
Paris, 17.th of May 2017
Poster Presentation: Okada K, Cutlip DE, Barakat M, Silber S, Erglis A, Honda Y on behalf of the COBRA PzF SHIELD Investigators
Final Optical Coherence Tomography Results from the COBRA PzF SHIELD Trial
Poster


60

International Conference on Nuclear Cardiology and Cardiac CT (ICNC)
Vienna, 9th of May 2017
Poster Presentation: Dr. med. M. Keller and Prof. Dr. S. Silber:
High Safety of Regadenoson for Myocardial Perfusion Imaging in a Cardiology Practice: Experience in over 4000 Patients

Poster


59


58


57


56

Annual Meeting of the German Society of Cardiology (DGK)
J.-N. Boeckel, L. Palapies, J. Klotsche, T. Zeller, B. von Jeisen, L. Pieper, S. Tzikas, D. Leistner, C. Bickel, G. K. Stalla, H. Lehnert, S. Silber, S. Baldus, W. März, S. Dimmeler, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller
Presentation: A new method to adjust Troponin I accounting for the confounders age, gender and kidney function facilitates clinical interpretation in patients with chest pain
Mannheim, April 2nd 2016


55

ESC Congress (European Society of Cardiology)
Piccolo R, Heg D, Rat, Franzone JA, Silber S, Serruys PW, Pigrim T, Juni P, Windecker S.
Comparative effectiveness and safety of new versus early generation drug-eluting stents according to the complexity of coronary artery disease. A patient level pooled analysis of 6,081 patients
download presentation
download abstract, European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 29
London, 29. August 2015


54

Fajadet J, Garcia E, Neumann FJ, Hildick-Smith D,  Petronio S, Spence M, Wöhrle J,  Zaman A, Elhadad S, Silber S
on behalf of the Platinum Plus Trial Investigators
Results of the Primary Endpoint of the Platinum Plus Trial:
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients
1 year results

TCT (Transcatheter Cardiovascular Therapeutics) 
San Francisco, Oktober 2013
Power Point Presentation


53

Symposium:
JIM - Joint Interventional Meeting
Presentations:

Live Case Commentator:
Live cases from Bonn, Germany

Rom, 14. - 15. Februar 2013


52

Fajadet J, Garcia E, Hildick-Smith D,  Petronio S, Silber S, Neumann FJ, Zaman A,  Wöhrle J, Spence M, Elhadad S
on behalf of the Platinum Plus Trial Investigators
A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients: PLATiNUM PLUS
1 month results
TCT (Transcatheter Cardiovascular Therapeutics) 
Miami, October 2012
Poster Presentation


51


50


49


48

XXI. Workshop of Interventional Cardiology:
Presentation: The Resolute Clinical Programme: Current Status
Hradec Králové, Czech Republic, 8. April 2011


47


46

Cardiology Update 2011
Revascularisation, ACS, Antithrombotics
Satellite Symposium

Presentation: Convincing New Stent Developments
Davos, Switzerland, 17. February 2011


45

Symposium:
JIM - Joint Interventional Meeting
Live Case Commentator
Life Cases from Milan, Italy
Life Cases from Essen, Germany
Rome, Italy, 10.-11. Februayr 2011


44


43

EuroPCR Symposium
What do Resolute All Comers Data tell us about the treatment of complex patients and complex lesions?

Chairman,
Presentation: Challenges in treating complex lesions: What answers does the Resolute All Comers trial provide?

Paris, France, 27. May 2010


42

Euro PCR
Evening Symposium
MGuard - two Years Experience in Acute MI
Panel

Paris, France, 26. May 2010


41

59th ESCVS International Congress
in conjunction with the 6th Congress of update in Cardiology and Cardiovascular Surgery - Heart and Health Foundation of Turkey (HHFT)
Lunch Symposium 
IAIC Session
Drug Eluting Stents: A new paradigm in interventionell cardiology

Presentations:

Izmir, Turkey, 17. April 2010


40

ACC
Coronary Artery Disease

Panel Discussion
Atlanta, USA, 14. March 2010